Historique
![Cychlorphine - EUDA initial report on the new psychoactive substance: 3-(3-{1-[1-(4-chlorophenyl)ethyl]piperidin-4-yl}-2-oxo-2,3-dihydro-1H-1,3-benzimidazol-1-yl)propanenitrile (cychlorphine)](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_89270.webp?v=1787060920)
Rapport
Cychlorphine - EUDA initial report on the new psychoactive substance: 3-(3-{1-[1-(4-chlorophenyl)ethyl]piperidin-4-yl}-2-oxo-2,3-dihydro-1H-1,3-benzimidazol-1-yl)propanenitrile (cychlorphine) : In accordance with Article 9 of Regulation (EU) 2023/1322
Auteur(s) :
EUDA (European Union Drugs Agency)
Année
2026
Page(s) :
29 p.
Langue(s) :
Anglais
Éditeur(s) :
Lisbon : European Union Drugs Agency (EUDA)
;
Luxembourg : Publications Office of the European Union
Collection :
Initial reports
ISBN :
978-92-9408-143-8
Domaine :
Drogues illicites
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Thésaurus géographique
UNION EUROPEENNE
;
EUROPE
Thésaurus mots-clés
OPIOIDES
;
DROGUES DE SYNTHESE
;
REGLEMENTATION
;
CHIMIE
;
FABRICATION
;
PRECURSEURS
;
TOXICOLOGIE
;
PHARMACOLOGIE
;
PHENOMENE EMERGENT
;
SAISIE
;
MARCHE DE LA DROGUE
;
CONTROLE DES STUPEFIANTS
;
SURVEILLANCE EPIDEMIOLOGIQUE
Résumé :
3-(3-{1-[1-(4-Chlorophenyl)ethyl]piperidin-4-yl}-2-oxo-2,3-dihydro-1H-1,3-benzimidazol-1-yl)propanenitrile, commonly known as cychlorphine, is a piperidine benzimidazolone and synthetic opioid belonging to the orphine opioids, a group of related new synthetic opioids. It is monitored by the EUDA as a new psychoactive substance through the European Union Early Warning System. Based on potential public health risks, an initial report has been prepared and submitted to the Commission and the Member States, in accordance with Article 9 of Regulation (EU) 2023/1322. Its purpose is to provide scientific evidence to the Commission to allow it to make an informed decision regarding whether or not there is a need to request a risk assessment on a new psychoactive substance. [Editor's abstract]
Autre(s) lien(s) :
News release (26/06/) ; Initial reports